What Pharmcube does

Pharmcube (医药魔方) is a Beijing-headquartered pharmaceutical data intelligence platform founded in 2015, operating under the legal entity Shanghai Huabin Licheng Technology Co., Ltd. The company operates a proprietary full-chain pharmaceutical data standard system integrated with AI intelligence technologies, covering investment financing, patent landscape, market competition, clinical research, regulatory approval, market access, sales, and medical evidence. It sells 12 enterprise-grade data products (InvestGO, MedAlpha, NextPat, NextPharma, NextDevice, NextBioSeq, PharmaGO, TrialiCube, and PharmaBI IPM/HCM/RCM/HPI), a media platform (魔方媒体) reaching 800,000+ industry readers, and a consulting practice (魔方咨询) spanning six project types across the drug lifecycle. The platform serves 1,000+ pharmaceutical companies and investment institutions, with 100万+ monthly data searches and 10+ years of accumulated pharmaceutical data.

The company operates enterprise sales with a subscription-based revenue model for data products, supplemented by media services and consulting engagements. Pricing is not publicly disclosed and the website features 'apply for trial' calls-to-action, consistent with a sales-led motion. Pharmcube has four offices across China (Beijing as headquarters, Shanghai in Zhangjiang Hi-Tech Park, Suzhou, and Nanjing), with a workforce of 101-250 employees including a high-caliber team where 56%+ hold master's degrees and 60%+ graduated from top-tier Chinese universities. The company holds multiple ISO certifications (27001, 20000, 9001, 37301, 45001), National High-Tech Enterprise status, and the Internet Drug Information Service Qualification, and is a member of the ZFIC Alliance to position Chinese biopharma innovation on the global stage.

Name

Pharmcube

Legal name

Shanghai Huabin Licheng Technology Co., Ltd. (上海华彬立成科技有限公司)

Website

https://pharmcube.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

101–250 employees

Short description

Pharmcube (医药魔方) is a Beijing-based pharmaceutical data intelligence platform founded in 2015, offering 12 enterprise data products, media services, and consulting solutions to 1,000+ pharmaceutical companies and investment institutions across China.

Ownership category

akta.pro rank

Product category

Pharmaceutical Data Analytics

NAICS

Software Publishers (5132)

SIC

Services-Prepackaged Software (7372)

akta.pro primary industry

Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)

akta.pro secondary industry

Healthcare & Life Sciences PR (MPAAADAD)

Keywords

• Pharmaceutical intelligence
• Drug pipeline data
• Clinical trial analytics
• Pharmaceutical consulting
• Healthcare investment data

Headquarters

HQ city

Beijing

HQ country

China

HQ region

Asia

Offices4 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

1. Data Products Subscription: Annual subscription-based access to Pharmcube's portfolio of enterprise data products including InvestGO, NextPharma, NextPat, NextBioSeq, PharmaGO, NextDevice, TrialiCube, and PharmaBI platforms serving pharmaceutical R&D, investment, and commercial teams.
2. Pharmaceutical Media Services: Daily pharmaceutical industry news delivery, industry trend analysis, policy interpretation, visualized scientific content design, live streaming, and offline events. Currently serves 300+ industry customers and reaches 800K+ subscribers.
3. Pharmaceutical Consulting Services: Professional consulting services covering competitive landscape analysis, clinical evaluation strategies, market potential assessment, pipeline planning, pricing and access strategy, and competitive company research across the pharmaceutical product lifecycle.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Core offering

Pharmcube operates a proprietary AI-powered pharmaceutical data platform providing subscription-based data products (InvestGO, NextPharma, NextPat, PharmaGO, NextDevice, NextBioSeq, TrialiCube, PharmaBI, MedAlpha), professional media services reaching 800K+ subscribers, and consulting across the full drug lifecycle. The platform covers investment financing, patent layout, market competition, clinical research, registration approval, market access, sales, and medical evidence.

Product overview

Pharmcube is a data-driven pharmaceutical intelligence platform offering a comprehensive portfolio of 12 enterprise-grade data products, media services, and consulting solutions. The platform is built on a proprietary full-chain pharmaceutical data standards system powered by AI technology. Core products include InvestGO® for investment financing intelligence, NextPharma® for new drug pipeline monitoring, NextPat® for patent search, PharmaGO® for drug information, TrialiCube® for clinical trials, and PharmaBI® products (IPM, HCM, RCM, HPI) for sales and market data across hospital, retail, and patient dimensions. Services include 魔方媒体 (media) serving 800,000+ industry readers and 魔方咨询 (consulting) covering six project types across the drug lifecycle.

Differentiator

Problem solved

Functional benefit

Brands

• InvestGO®: Global medical health investment data platform covering biopharma investment and financing intelligence.
• NextPharma®
• NextPat®
• PharmaGO®
• NextDevice®
• NextBioSeq®
• TrialiCube®
• PharmaBI® IPM
• PharmaBI® HCM
• PharmaBI® RCM
• PharmaBI® HPI
• MedAlpha®

Products and services

• InvestGO®

Quantifiable outcome

• Over 1 million monthly data searches
• +2 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature3 records

Partnerships

One partnership is on record.

• ZFIC Alliance (ZFIC联盟)minorStrategic or Co-development PartnerPharmcube participates in the ZFIC (FIC Pharma) Alliance, a collaborative network for China's pharmaceutical innovation ecosystem. The company organized the 2026 China FIC Innovation and Collaboration Summit alongside the J.P. Morgan Healthcare Conference in San Francisco, showcasing Chinese pharmaceutical companies' R&D platforms and clinical pipelines to the global biopharma industry.

Scale indicators5 records

Recent moves6 records

Expansion highlights12 records

Others

• Patentics: Patentics is a patent search and analytics platform widely used in Chinese pharma IP analysis. It is adjacent rather than directly competitive with Pharmcube, but overlaps with the NextPat product in serving pharma patent intelligence use cases for IP and BD teams.

Broad incumbents

• GlobalData: GlobalData provides pharmaceutical, healthcare, and industry intelligence including drug pipeline, clinical trials, deals, and market forecasts. Competes with Pharmcube in pharma competitive intelligence and market data, with broader geographic coverage and stronger enterprise sales globally.
• Clarivate: Clarivate (Cortellis, Derwent, BioWorld) provides pharmaceutical and intellectual property intelligence spanning drug pipelines, patents, clinical trials, and regulatory landscapes. Overlaps with Pharmcube's NextPharma, NextPat, and TrialiCube offerings but at global scale with deeper longitudinal datasets.
• Evaluate Pharma: Evaluate (now part of Norstella) provides pharmaceutical commercial intelligence including drug sales forecasts, R&D pipeline analytics, and deal data. Overlaps with Pharmcube's PharmaBI commercial data and InvestGO investment intelligence products at the high end of the enterprise market.
• Citeline / Informa Pharma Intelligence: Citeline (Pharmaprojects, Trialtrove, Sitetrove) offers global pharmaceutical pipeline, clinical trial, and site intelligence data. Directly comparable to Pharmcube's NextPharma and TrialiCube products but with substantially broader global coverage and deeper clinical trial dataset depth.
• IQVIA: IQVIA is the global leader in life sciences data, analytics, and clinical research services, offering pharma intelligence across clinical trials, R&D, commercial, and real-world evidence. Competes with Pharmcube at the high end of the Chinese pharma intelligence market, particularly for multinational pharma customers seeking global-grade datasets.

Emerging players

• DrugBank: DrugBank is a structured pharmaceutical knowledge base providing detailed drug, target, and mechanism data widely used in pharma R&D. Comparable to elements of Pharmcube's PharmaGO product in providing comprehensive drug information, though more focused on chemistry/biology than commercial intelligence.
• PharmaCompass: PharmaCompass is a global pharmaceutical data platform offering drug pipelines, prices, approvals, and supplier intelligence. Competes with elements of Pharmcube's NextPharma and PharmaGO products but with a broader international supplier and pricing focus rather than China-specific depth.

Direct peers

• Yaorui Cloud / Insight Medical (药融云): Yaorui Cloud is a Chinese pharmaceutical big data and information service platform covering drug pipelines, clinical trials, patents, registration, and market data. Comparable to Pharmcube in offering a comprehensive China-focused pharma data subscription suite plus consulting-style value-added services.
• Yaozhi (药智数据): Yaozhi Data is a leading Chinese pharmaceutical data intelligence platform offering drug R&D, clinical trial, patent, regulatory, and market data products. It is the closest direct competitor to Pharmcube within China, targeting the same enterprise pharma and investment customer segments with similar subscription-based data products.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles15 records

Funding overview

Funding rounds2 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pharmcube